Additionally, targeting Drp1 expression with Mdivi-1 or miR-203a-3p can significantly inhibited the metastasis of ESCC cells both in vitro and in vivo through the ROS-PGC1-α-Nrf1/2 pathway. This evidence concerns the gene DNM1L and esophageal squamous cell carcinoma.